Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat sodium and dexamethasone in ARDS
NCT06387823Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sivelestat in acute respiratory distress syndrome (ARDS), sponsored by Peking Union Medical College Hospital. Started Apr 2024; status: recruiting.
02
Drugs
sivelestat
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT06387823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06387823.